Onyx's lawsuit against Bayer over their joint venture on cancer drug Nexavar reads like a love affair gone wrong -- complete with allegations of Bayer going behind Onyx's back, cheating on the company ...
This stock just hit a 52-week milestone. Where will it head from here? Shares of Onyx Pharmaceuticals (Nasdaq: ONXX) hit a 52-week high today. Let's take a look at how it got there and see if clear ...
After a $3.8 million hack on a long-known security vulnerability, Onyx plans to relaunch its governance-focused financial network with full community support. After losing $3.8 million in a Sept. 27 ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. MARYLAND HEIGHTS, MO (KTVI) – Onyx is this ...
Romantasy is on fire these days, literally. Because who wouldn’t want all the sexy fun of a romance PLUS dragons? We couldn’t tell you that. But we can tell you who definitely does: Fourth Wing fans.
The Onyx Boox Nova3 Color bridges the gap between an e-reader and a true Android tablet. E-readers deliver long-lasting battery life and can store tons of content, but often without nearly as much ...
Mokwheel’s brand-new Onyx Series—available as the classic Onyx and the step-through Onyx ST—brings serious power and precision to the all-terrain e-bike scene. With a 750 W mid-drive motor (1,300 W ...
The new E Ink tablet is similar to the monochromatic Boox Tab Ultra and shares the same rear camera. However, it features a Kaleido 3 E Ink screen, which should make colors look more vivid than other ...
At PEDESTRIAN.TV, we independently choose and write about stuff we love and think you’ll froth too. We have affiliate partnerships so we might get a bit of money from any purchase you make based on ...
Selling prerecorded exercise videos for at-home workouts has been a viable business model for decades, and the pandemic has only increased the need for home solutions spanning every conceivable ...
On Friday,The Financial Post, a Canadian newspaper, reported that Amgen had made a $120 a share offer for Onyx Pharmaceuticals, the South San Francisco-based biotech whose stock traded for almost $87 ...